Inogen names Andrew Reding EVP and Chief Operating Officer, effective July 6, 2026

Inogen appointed Andrew (Andy) Reding as Executive Vice President and Chief Operating Officer, effective July 6, 2026.Original SEC Filing: Inogen Inc [ INGN ] - 8-K - Jul. 01, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. P…

Inogen appointed Andrew (Andy) Reding as Executive Vice President and Chief Operating Officer, effective July 6, 2026.

IndividualAndrew (Andy) Reding

RoleExecutive Vice President, Chief Operating Officer

Type of ChangeAppointed

Effective DateJuly 6, 2026

ReasonAppointment by Board

Replacement InfoNot disclosed

Background DetailsFormer Chief Commercial Officer at Viant Medical (Sept 2020–Mar 2026); VP & GM at Hillrom Respiratory Health (2015–2020); senior roles at Trumpf Medical Systems. Masters in business administration (Univ. of South Carolina); BA in business administration & English (Marquette University).

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.